iPredict Eye Screening
Overview
iHealthScreen harnesses artificial intelligence and retinal imaging to provide a HIPAA-compliant platform for the early diagnosis of various eye and systemic diseases. The company’s flagship product, iPredict, offers automated screening for Age-Related Macular Degeneration (AMD), Diabetic Retinopathy (DR), and Glaucoma in primary care settings. Beyond ophthalmic conditions, iHealthScreen also provides an online risk prediction system for systemic diseases such as diabetes, stroke, and heart attack. The technology aims to prevent blindness and save lives by making screening accessible and affordable, delivering fast and accurate results in minutes. iHealthScreen also offers Electronic Health Record (EHR) solutions and AI-based telemedicine services to streamline healthcare delivery and improve patient outcomes.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- AI-Based Screening for Diabetic Retinopathy (DR), Age-related Macular Degeneration (AMD), and Glaucoma
- Electronic Health Record (EHR) Solutions
- AI-Based Telemedicine Service
- Image Analyzer for Retinal Vessel, Retinal Pathology, and OCT Inspector
- Online Health Risk Prediction System for Diabetic, Stroke, and Heart Attack patients
- Fast results: test completed in less than 5 minutes, report in under 60 seconds
- High accuracy: approximately 95% on average (AMD sensitivity 86.86%, specificity 94.13%)
- Easy to operate, non-invasive, with an advanced touchscreen interface
- Accessible for use in primary care settings
- Digital Prescription capabilities integrated within EHR
Use Cases
- Early screening and diagnosis of Age-Related Macular Degeneration (AMD)
- Early screening and diagnosis of Diabetic Retinopathy (DR)
- Early screening and diagnosis of Glaucoma
- Prediction of risk for stroke and heart attack
- Telemedicine consultations and remote patient care
- Retinal image analysis for various pathologies
Details
| Category | Cardiology AI, Neurology AI, Ophthalmology AI |
| Pricing |
Contact for pricing
|
| Deployment | Cloud-based (Software as a Medical Device), accessible in primary care settings, clinics, hospitals, and online for telemedicine and prediction apps. |
| Compliance | |
| BAA Available | Unknown AI-estimated |
| HIPAA Compliant | Unknown AI-estimated |
| FDA Status |
1 AI-estimated FDA 510(k) cleared for age-related macular degeneration (AMD) in patients aged 50 years and older (K231454, cleared June 2023). FDA 510(k) submitted for Diabetic Retinopathy (DR) with clearance expected by mid-2025. The system is also CE Certified in Europe, UK, Australia, and UAE for AMD, DR, and Glaucoma screening. |
| Integrations | |
| EHR | Not specified |
| Specialties | Family Medicine, Internal Medicine, Ophthalmology |
What the Web Says
iPredict Eye Screening, developed by iHealthScreen, is an AI-powered, cloud-based software that screens for diabetic retinopathy (DR), age-related macular degeneration (AMD), and glaucoma using retinal color fundus images. It aims to provide early diagnosis and facilitate timely referrals, particularly in primary care settings. The system is designed to be fast, accurate, and easy to operate, with reports generated in less than a minute and the entire test completed within five minutes.
Overall: PositiveStrengths
- Early detection and diagnosis of DR, AMD, and glaucoma, potentially preventing blindness.
- Fast and efficient screening process, with results in under a minute and the full test in under five minutes.
- Can be integrated into primary care practices, increasing accessibility to eye screenings.
- Minimally invasive and easy to operate, requiring less than an hour of training for staff.
- High accuracy rates reported for detecting various eye conditions.
- Received CE certification, TGA approval (Australia), MHRA approval (UK), and US patents for AMD and glaucoma detection, with FDA 510(k) clearance for iPredict-DR.
Limitations
- Further future studies are required to assess the impact and efficacy of the system, especially regarding report quality in the presence of media opacities like cataracts.
- While the model is not designed to detect diseases other than AMD, it has identified some concomitant diseases, which could be an added benefit but also highlights a potential limitation in its specific diagnostic scope.
- Some Reddit discussions about eye screening photos in general mention potential concerns about optional charges and whether they replace traditional dilation, suggesting a need for clear communication on benefits and insurance coverage.
- One Reddit thread discusses AI eye scans for predicting cognitive decline and dementia, which, while a positive use of AI, is a different application than iPredict's primary focus on DR, AMD, and glaucoma, indicating a broader landscape of AI in ophthalmology that iPredict currently doesn't cover.
Based on reviews from: Health Technology Review, Optometry Times, iHealthScreen receives US patent for iPredict glaucoma detection model, iPredict-DR Automated Diabetic Retinopathy Screening Tool to Help Prevent Blindness, A prospective study for validating an automated AI-based system for detecting age-related macular degeneration in clinical settings - PMC, iHealthScreen submits AI-based AMD screening tool to FDA for 510(k) clearance, iHealthScreen Inc. applies for FDA 510K Submission for iPredictu2122, an AI-based, software as a medical device tool to diagnosis AMD | Eye Care Network - Modern Retina - Ophthalmology Times, iHealthScreen Website, Study Details | NCT07084883 | Pivotal Trial of an Automated AI-based System for Early Diagnosis and Prediction of Late Age-related Macular Degeneration, AI-powered AMD screening tool receives FDA clearance - Healio, A scoping review of artificial intelligence as a medical device for ophthalmic image analysis in Europe, Australia and America - PMC, An Artificial-Intelligence- and Telemedicine-Based Screening Tool to Identify Glaucoma Suspects from Color Fundus Imaging - PMC, IHealthScreen nabs FDA nod for AI-backed dx to spot mild diabetic retinopathy, Fully Automated Software for Glaucoma Screening iPredictu2122 which utilizes retinal color fundus image and AI based tool - iHealthScreen, FDA clears iHealthScreen's AI diabetic retinopathy screening software, Breakthrough AI-powered eye scan predicts risk of cognitive decline and dementia - The Brighter Side of News - Reddit, iHealthScreen Receives U.S. FDA 510(k) Clearance (K253704) for iPredict-DR, an AI-Powered Software for Automated Diabetic Retinopathy Screening - Business Wire, Researchers have found that artificial intelligence (AI) can help identify serious lung and heart complications in premature infants by analyzing images already collected during routine eye screenings. : r/science - Reddit, AI tool can scan your retina and predict your risk of heart disease 'in 60 seconds or less', School's eye screener test detected eye issue in kindergartner despite passing standard eye test at pediatrician : r/kindergarten - Reddit, Yearly Eye Exam - they want to charge me $40 for 'Eye Screening Photo' - Legit? - Reddit
Last updated: 2026-08-13
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate iPredict Eye Screening
Press & Coverage
Videos
Product demos, reviews, and walkthroughs for iPredict Eye Screening.
iHealthScreen: Q&A Webinar Recap
iHealthScreen
iPredict-DR Automated Diabetic Retinopathy Screening Tool to Help Prevent Blindness
iHealthScreen
Screening Solution by iHealthScreen Inc.
iHealth Screen Inc
iHealthScreen's Highlight
iHealthScreen Ltd
Diabetic retinopathy screening: u09a1u09beu09afu09bcu09beu09acu09c7u099fu09bfu09b8 u09a5u09c7u0995u09c7 u0985u09a8u09cdu09a7u09a4u09cdu09ac | Ai eye screening | Diabetes & blindness
myHealth
Frequently Asked Questions
Compare iPredict Eye Screening
VS
VS
VS
VS
